Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma

Maye Griebel, Henry S. Friedman, Edward C. Halperin, M. David Wiener, Lawrence Marks, W. Jerry Oakes, John M. Hoffman, G. Robert DeLong, S. Clifford Schold, Beverly Hockenberger, Carolyn R. Freeman, Larry Kun

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Two patients with brain stem gliomas were treated with hyperfractionated radiation therapy (HFR) (7,020 and 7,560 cGy, respectively). Despite initial clinical improvement during irradiation, both patients demonstrated clinical deterioration approximately 3 weeks after completion of radiotherapy. Cranial magnetic resonance imaging (MRI) revealed a progressive increase in distribution of abnormal brain stem signal consistent with either tumor or edema. 18FDG positron emission tomography (PET) was obtained in one patient and demonstrated a hypermetabolic lesion at diagnosis and a hypometabolic lesion at the time of clinical deterioration postirradiation. Management with a tapering dose of dexametha‐sone alone resulted in marked clinical (both patients) and radiogaphic (one patient) improvement, allowing reduction or discontinuation of this medication. These results suggest that patients with brain stem tumors demonstrating clinical and radiographic evidence of progressive tumor shortly after completion of HFR should be initially managed conservatively with dexamethasone, since these findings may be manifestations of reversible radiation‐related neurotoxicity.

Original languageEnglish (US)
Pages (from-to)182-186
Number of pages5
JournalMedical and Pediatric Oncology
Volume19
Issue number3
DOIs
StatePublished - Jan 1 1991

Fingerprint

Glioma
Brain Stem
Radiotherapy
Dexamethasone
Brain Stem Neoplasms
Fluorodeoxyglucose F18
Positron-Emission Tomography
Edema
Neoplasms
Magnetic Resonance Imaging

Keywords

  • brain stem glioma
  • hyperfractionated irradiation
  • positron emission tomography

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research

Cite this

Griebel, M., Friedman, H. S., Halperin, E. C., Wiener, M. D., Marks, L., Oakes, W. J., ... Kun, L. (1991). Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma. Medical and Pediatric Oncology, 19(3), 182-186. https://doi.org/10.1002/mpo.2950190307

Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma. / Griebel, Maye; Friedman, Henry S.; Halperin, Edward C.; Wiener, M. David; Marks, Lawrence; Oakes, W. Jerry; Hoffman, John M.; DeLong, G. Robert; Schold, S. Clifford; Hockenberger, Beverly; Freeman, Carolyn R.; Kun, Larry.

In: Medical and Pediatric Oncology, Vol. 19, No. 3, 01.01.1991, p. 182-186.

Research output: Contribution to journalArticle

Griebel, M, Friedman, HS, Halperin, EC, Wiener, MD, Marks, L, Oakes, WJ, Hoffman, JM, DeLong, GR, Schold, SC, Hockenberger, B, Freeman, CR & Kun, L 1991, 'Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma', Medical and Pediatric Oncology, vol. 19, no. 3, pp. 182-186. https://doi.org/10.1002/mpo.2950190307
Griebel, Maye ; Friedman, Henry S. ; Halperin, Edward C. ; Wiener, M. David ; Marks, Lawrence ; Oakes, W. Jerry ; Hoffman, John M. ; DeLong, G. Robert ; Schold, S. Clifford ; Hockenberger, Beverly ; Freeman, Carolyn R. ; Kun, Larry. / Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma. In: Medical and Pediatric Oncology. 1991 ; Vol. 19, No. 3. pp. 182-186.
@article{d1e4a36ff40544599a671fe97face79b,
title = "Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma",
abstract = "Two patients with brain stem gliomas were treated with hyperfractionated radiation therapy (HFR) (7,020 and 7,560 cGy, respectively). Despite initial clinical improvement during irradiation, both patients demonstrated clinical deterioration approximately 3 weeks after completion of radiotherapy. Cranial magnetic resonance imaging (MRI) revealed a progressive increase in distribution of abnormal brain stem signal consistent with either tumor or edema. 18FDG positron emission tomography (PET) was obtained in one patient and demonstrated a hypermetabolic lesion at diagnosis and a hypometabolic lesion at the time of clinical deterioration postirradiation. Management with a tapering dose of dexametha‐sone alone resulted in marked clinical (both patients) and radiogaphic (one patient) improvement, allowing reduction or discontinuation of this medication. These results suggest that patients with brain stem tumors demonstrating clinical and radiographic evidence of progressive tumor shortly after completion of HFR should be initially managed conservatively with dexamethasone, since these findings may be manifestations of reversible radiation‐related neurotoxicity.",
keywords = "brain stem glioma, hyperfractionated irradiation, positron emission tomography",
author = "Maye Griebel and Friedman, {Henry S.} and Halperin, {Edward C.} and Wiener, {M. David} and Lawrence Marks and Oakes, {W. Jerry} and Hoffman, {John M.} and DeLong, {G. Robert} and Schold, {S. Clifford} and Beverly Hockenberger and Freeman, {Carolyn R.} and Larry Kun",
year = "1991",
month = "1",
day = "1",
doi = "10.1002/mpo.2950190307",
language = "English (US)",
volume = "19",
pages = "182--186",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma

AU - Griebel, Maye

AU - Friedman, Henry S.

AU - Halperin, Edward C.

AU - Wiener, M. David

AU - Marks, Lawrence

AU - Oakes, W. Jerry

AU - Hoffman, John M.

AU - DeLong, G. Robert

AU - Schold, S. Clifford

AU - Hockenberger, Beverly

AU - Freeman, Carolyn R.

AU - Kun, Larry

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Two patients with brain stem gliomas were treated with hyperfractionated radiation therapy (HFR) (7,020 and 7,560 cGy, respectively). Despite initial clinical improvement during irradiation, both patients demonstrated clinical deterioration approximately 3 weeks after completion of radiotherapy. Cranial magnetic resonance imaging (MRI) revealed a progressive increase in distribution of abnormal brain stem signal consistent with either tumor or edema. 18FDG positron emission tomography (PET) was obtained in one patient and demonstrated a hypermetabolic lesion at diagnosis and a hypometabolic lesion at the time of clinical deterioration postirradiation. Management with a tapering dose of dexametha‐sone alone resulted in marked clinical (both patients) and radiogaphic (one patient) improvement, allowing reduction or discontinuation of this medication. These results suggest that patients with brain stem tumors demonstrating clinical and radiographic evidence of progressive tumor shortly after completion of HFR should be initially managed conservatively with dexamethasone, since these findings may be manifestations of reversible radiation‐related neurotoxicity.

AB - Two patients with brain stem gliomas were treated with hyperfractionated radiation therapy (HFR) (7,020 and 7,560 cGy, respectively). Despite initial clinical improvement during irradiation, both patients demonstrated clinical deterioration approximately 3 weeks after completion of radiotherapy. Cranial magnetic resonance imaging (MRI) revealed a progressive increase in distribution of abnormal brain stem signal consistent with either tumor or edema. 18FDG positron emission tomography (PET) was obtained in one patient and demonstrated a hypermetabolic lesion at diagnosis and a hypometabolic lesion at the time of clinical deterioration postirradiation. Management with a tapering dose of dexametha‐sone alone resulted in marked clinical (both patients) and radiogaphic (one patient) improvement, allowing reduction or discontinuation of this medication. These results suggest that patients with brain stem tumors demonstrating clinical and radiographic evidence of progressive tumor shortly after completion of HFR should be initially managed conservatively with dexamethasone, since these findings may be manifestations of reversible radiation‐related neurotoxicity.

KW - brain stem glioma

KW - hyperfractionated irradiation

KW - positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=0025805686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025805686&partnerID=8YFLogxK

U2 - 10.1002/mpo.2950190307

DO - 10.1002/mpo.2950190307

M3 - Article

C2 - 1902547

AN - SCOPUS:0025805686

VL - 19

SP - 182

EP - 186

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -